Search Login Register

Ondansetron (Zofran) Summary

Description: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Also Known As: Zofran; SN 307; GR-38032F; GR38032F; Ondansetron Hydrochloride Show All >>

Networked: 1871 relevant articles (552 outcomes, 615 trials/studies) for this Drug

Key Diseases for which Ondansetron is Relevant

  1. Vomiting : 290 outcomes 287 studies in 1071 results
  2. Postoperative Nausea and Vomiting (PONV) : 207 outcomes 194 studies in 487 results
  3. Nausea : 184 outcomes 161 studies in 751 results
  4. Neoplasms (Cancer) : 23 outcomes 36 studies in 160 results
  5. Pruritus (Itching) : 22 outcomes 23 studies in 67 results
Show All >>

Drugs Related to Ondansetron

  1. Dexamethasone (Maxidex)
  2. Metoclopramide (Reglan)
  3. Cisplatin (Platino)
  4. Droperidol
  5. Granisetron (Kytril)
  6. Serotonin (5 Hydroxytryptamine)
  7. Cyclophosphamide (Cytoxan)
  8. ramosetron (Nasea)
  9. Antiemetics
  10. Ondansetron (Zofran)
Show All >>

Therapies Related to Ondansetron

  1. Drug Therapy (Chemotherapy)
  2. Laparoscopic Cholecystectomy
  3. General Anesthesia
  4. Tonsillectomy
  5. Patient-Controlled Analgesia (Analgesia, Patient Controlled)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.